Not Tagged
abbvie
['abbvie']
join at #acg2022 as he shares results from a study on developing the first clinical screening tool for epi (exocrine pancreatic insufficiency) in patients with #chronicpancreatitis. learn more: 
AbbVie’s Twitter feed featuring news and updates from our U.S. business. Intended for U.S. residents only. Review our guidelines here: https://t.co/CMljIbzTPP